UNAUDITED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Common Stock [Member]	Treasury Stock, Common [Member]	Additional Paid-in Capital [Member]	Stock Subscription [Member]	Comprehensive Income [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Mar. 31, 2022	$ 802,633		$ 17,942,833	$ 136,721	$ 14,599	$ (7,833,790)	$ 11,062,996
Shares, Issued at Mar. 31, 2022	802,633,333
Foreign currency translation					43,152		43,152
Shares issued for cash	$ 280		136,721	(136,721)			280
[custom:StockIssuedDuringPeriodSharesForCash]	280,000
Shares issued for cash	$ 385		49,615				50,000
Stock Issued During Period, Shares, New Issues	384,615
Shares issued for services	$ 1,500		319,500				321,000
Stock Issued During Period, Shares, Issued for Services	1,500,000
Shares issued for services- directors	$ 2,250		479,250				481,500
Stock Issued During Period, Shares, Employee Benefit Plan	2,250,000
Net loss						(1,722,691)	(1,722,691)
Ending balance, value at Dec. 31, 2022	$ 807,048		18,927,919		57,751	(9,556,481)	10,236,237
Shares, Issued at Dec. 31, 2022	807,047,948
Beginning balance, value at Mar. 31, 2023	$ 807,048		18,927,919		(63,173)	(9,576,247)	10,095,547
Shares, Issued at Mar. 31, 2023	807,047,948
Foreign currency translation					74,144		74,144
Shares issued for services	$ 16,088	$ (16,088)	305,672				305,672
Stock Issued During Period, Shares, Issued for Services	16,088,000	(16,088,000)
Shares issued for services- directors	$ 9,000	$ (9,000)	171,000				171,000
Stock Issued During Period, Shares, Employee Benefit Plan	9,000,000	(9,000,000)
Net loss						(2,865,209)	(2,865,209)
Shares reclaimed into treasury shares	$ (44,064)	$ 44,064
Stock Issued During Period, Shares, Treasury Stock Reissued	(44,064,000)	44,064,000
Shares issued for warrants	$ 13,500	$ (13,500)
Stock Issued During Period, Shares, Conversion of Convertible Securities	13,500,000	(13,500,000)
Shares issued for acquisition of Alinova Resources	$ 5,000	$ (5,000)	295,000				295,000
Stock Issued During Period, Shares, Acquisitions	5,000,000	(5,000,000)
Shares issued for settlement of debt	$ 476	$ (476)	157,339				157,339
Stock Issued During Period, Shares, Other	476,000	(476,000)
Shares reclaimed from asset sale	$ (24,000)	$ 24,000	(12,000,000)				(12,000,000)
[custom:StockReclaimedDuringPeriodSharesAcquisitionCancellation]	(24,000,000)	24,000,000
Additional shares reclaimed from asset sale	$ (5,016)	$ 5,016
[custom:StockReclaimedAdditionalDuringPeriodSharesAcquisitionCancellation]	(5,015,993)	5,015,993
Shares issued for conversion of debt	$ 587,500		1,762,500				2,350,000
[custom:StockIssuedDuringPeriodSharesConversionOfDebt]	587,499,996
Shares issued for outside services	$ 8,360		21,737				30,097
[custom:StockIssuedDuringPeriodSharesOutsideServices]	8,360,306
Shares issued for services – internal	$ 8,771		22,804				31,575
[custom:StockIssuedDuringPeriodSharesInternalServices]	8,770,695
Ending balance, value at Dec. 31, 2023	$ 1,382,663	$ 29,016	$ 9,663,971		$ 10,971	$ (12,441,456)	$ (1,354,835)
Shares, Issued at Dec. 31, 2023	1,382,662,952	29,015,996

ALTEROLA BIOTECH INC. 10-Q/A